GP Clinical Assessment Service - Cat 3 & 4

Award

Value

£3,651,515

Classifications

  • General-practitioner services
  • Services provided by medical personnel

Tags

  • award
  • contract

Published

2 years ago

Description

Intention to award a Public Services Contract under Regulation 32(2) (b) (ii) of the Public Contract Regulations 2015 for the provision of a GP Lead Clinical Assessment Service for Cat 3 & 4 - to allow for calls to the Urgent Care phone line to be assessed by GPs over the telephone, reducing the need for dispatching ambulances in cases where the medical need would be better served by a different clinical solution. Achieving an 80% downgrade rate.
The Negotiated Procedure without Prior Publication is being followed and is justified under Regulation 32 (2) (b) (ii).

Similar Contracts

Open

SWL ICB Framework Agreement for the Provision of Primary Care at Scale (PCAS) Services - Reopening

NHS South West London Integrated Care Board (NHS SWL ICB) is seeking to select further providers to be party to the existing Primary Care at Scale Framework Agreement. The current framework agreement is from 01 March 2025 until 28 February 2029. Duration of the framework agreement for the providers who will be added to the framework as a result of this procurement process will be 1st of April 2026 to 28 February 2029. The Framework Agreement is comprised of six (6) Lots. Details of each Lot are as follows: Lot 1 - Croydon Lot 2 - Kingston Lot 3 - Merton Lot 4 - Richmond Lot 5 - Sutton Lot 6 - Wandsworth The framework agreement will be used by NHS SWL ICB only. • Providers currently appointed to the framework for all Lots are not required to submit a tender under this procurement process. Your existing framework agreement will remain in effect until its scheduled expiry date of 28 February 2029. • Providers currently on the framework but not appointed to all Lots may express an interest for the Lots for which they are not presently included. • Providers not currently on the framework are eligible to submit a tender for any or all Lots. As advertised, the anticipated, framework total value is £52,000,000 (exclusive of VAT) with an annual value estimated at £13,000,000 (exclusive of VAT). Whilst this procurement opportunity has been advertised to have a potential total value of £52,000,000 the Relevant Authority will give no commitment to the actual level of commissioning activity under this Framework Agreement. The Services to which this Procurement relates fall within the scope of Schedule 1 of the Health Care Services (Provider Selection Regime) Regulations 2023. As such, the procurement of the Services is being run as a bespoke, single-stage application process akin to the Open Procedure. To download the tender documentation, interested service providers need to register on Atamis if they are not registered already. This can be done by clicking the link below https://health-family.force.com/s/Welcome Once registered, you can express an interest in this project by clicking the following the link to this specific project ; https://health-family.force.com/s/Welcome Contract Reference : C406528 Please note the documents are free of charge to access:

Open

Provision of Hypertension and Lipids Management Services

NHS Norfolk and Waveney Integrated Care Board is seeking a procure a Hypertension and Lipids Optimisation service. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.<br/><br/>NHS Norfolk and Waveney Integrated Care Board is seeking to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.<br/><br/>The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.<br/><br/>The successful provider is expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.<br/>Prescribers must be able to initiate relevant medicines.<br/>Prescribers must initiate medicines in line with N&W criteria.<br/><br/>Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.<br/><br/>Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.<br/><br/>The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete